{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:10:07Z","timestamp":1784916607552,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-023-10372-9","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T04:30:34Z","timestamp":1701232234000},"page":"277-286","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pulmonary hypertension secondary to valvular heart disease: a state-of-the-art review"],"prefix":"10.1007","volume":"29","author":[{"given":"Bansi","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamanna","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-4778","authenticated-orcid":false,"given":"Amin","family":"Yehya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"issue":"4","key":"10372_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","volume":"4","author":"MM Hoeper","year":"2016","unstructured":"Hoeper MM, Humbert M, Souza R et al (2016) A global view of pulmonary hypertension. Lancet Respir Med 4(4):306\u2013322. https:\/\/doi.org\/10.1016\/S2213-2600(15)00543-3","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10372_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcmg.2014.12.003","volume":"8","author":"J Magne","year":"2015","unstructured":"Magne J, Pibarot P, Sengupta PP, Donal E, Rosenhek R, Lancellotti P (2015) Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. JACC Cardiovasc Imaging 8(1):83\u201399. https:\/\/doi.org\/10.1016\/j.jcmg.2014.12.003","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"10372_CR3","doi-asserted-by":"publisher","first-page":"e029024","DOI":"10.1161\/JAHA.122.029024","volume":"12","author":"BA Maron","year":"2023","unstructured":"Maron BA (2023) Revised definition of pulmonary hypertension and approach to management: a clinical primer. J Am Heart Assoc 12(8):e029024. https:\/\/doi.org\/10.1161\/JAHA.122.029024","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10372_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL et al (2016) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37(1):67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317","journal-title":"Eur Heart J"},{"issue":"7","key":"10372_CR5","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","volume":"179","author":"MR Fisher","year":"2009","unstructured":"Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179(7):615\u2013621. https:\/\/doi.org\/10.1164\/rccm.200811-1691OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10372_CR6","doi-asserted-by":"publisher","first-page":"e001103","DOI":"10.1161\/JAHA.114.001103","volume":"3","author":"S Greiner","year":"2014","unstructured":"Greiner S, Jud A, Aurich M et al (2014) Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. J Am Heart Assoc 3(4):e001103. https:\/\/doi.org\/10.1161\/JAHA.114.001103","journal-title":"J Am Heart Assoc"},{"key":"10372_CR7","doi-asserted-by":"publisher","unstructured":"Yehya A, Polsani V, Martin RP (2017) Imaging assessment of functional tricuspid regurgitation. In: Chan KMJ (ed)\u00a0Functional mitral and tricuspid regurgitation: pathophysiology, assessment and treatment. Springer International Publishing; 167\u2013179. https:\/\/doi.org\/10.1007\/978-3-319-43510-7_20","DOI":"10.1007\/978-3-319-43510-7_20"},{"issue":"2","key":"10372_CR8","doi-asserted-by":"publisher","first-page":"e003973","DOI":"10.1161\/CIRCOUTCOMES.117.003973","volume":"11","author":"TD Wijeratne","year":"2018","unstructured":"Wijeratne TD, Lajkosz K, Brogly SB et al (2018) Increasing incidence and prevalence of WHO groups 1\u20134 pulmonary hypertension: a population-based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes 11(2):e003973. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.117.003973","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10372_CR9","doi-asserted-by":"publisher","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","volume":"61","author":"M Humbert","year":"2023","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2023) 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61(1):2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","journal-title":"Eur Respir J"},{"key":"10372_CR10","doi-asserted-by":"publisher","unstructured":"Simonneau G, Montani D, Celermajer DS et al (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53(1). https:\/\/doi.org\/10.1183\/13993003.01913-2018","DOI":"10.1183\/13993003.01913-2018"},{"key":"10372_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fcvm.2018.00040","volume":"5","author":"MT Maeder","year":"2018","unstructured":"Maeder MT, Weber L, Buser M et al (2018) Pulmonary hypertension in aortic and mitral valve disease. Front Cardiovasc Med 5:40. https:\/\/doi.org\/10.3389\/fcvm.2018.00040","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"10372_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","volume":"37","author":"S Rosenkranz","year":"2016","unstructured":"Rosenkranz S, Gibbs JSR, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachi\u00e9ry JL (2016) Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37(12):942\u2013954. https:\/\/doi.org\/10.1093\/eurheartj\/ehv512","journal-title":"Eur Heart J"},{"issue":"4","key":"10372_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/hrt.20.4.557","volume":"20","author":"P Wood","year":"1958","unstructured":"Wood P (1958) Pulmonary hypertension with special reference to the vasoconstrictive factor*. Br Heart J 20(4):557\u2013570","journal-title":"Br Heart J"},{"issue":"2","key":"10372_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/0970-9185.94916","volume":"28","author":"PK Neema","year":"2012","unstructured":"Neema PK, Rathod RC (2012) Pulmonary artery hypertension in mitral stenosis: role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance. J Anaesthesiol Clin Pharmacol 28(2):261\u2013262. https:\/\/doi.org\/10.4103\/0970-9185.94916","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"1","key":"10372_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/hrt.37.1.26","volume":"37","author":"HD Tandon","year":"1975","unstructured":"Tandon HD, Kasturi J (1975) Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J 37(1):26\u201336. https:\/\/doi.org\/10.1136\/hrt.37.1.26","journal-title":"Br Heart J"},{"issue":"5","key":"10372_CR16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/01.cir.79.5.1061","volume":"79","author":"MJ Levine","year":"1989","unstructured":"Levine MJ, Weinstein JS, Diver DJ et al (1989) Progressive improvement in pulmonary vascular resistance after percutaneous mitral valvuloplasty. Circulation 79(5):1061\u20131067. https:\/\/doi.org\/10.1161\/01.cir.79.5.1061","journal-title":"Circulation"},{"issue":"4","key":"10372_CR17","first-page":"391","volume":"37","author":"CH Ruan","year":"2010","unstructured":"Ruan CH, Dixon RAF, Willerson JT, Ruan KH (2010) Prostacyclin therapy for pulmonary arterial hypertension. Tex Heart Inst J 37(4):391\u2013399","journal-title":"Tex Heart Inst J"},{"issue":"5","key":"10372_CR18","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jtcvs.2016.09.017","volume":"153","author":"B Yang","year":"2017","unstructured":"Yang B, Likosky DS, Bolling SF (2017) Mitral stenosis with pulmonary hypertension: we should operate early. J Thorac Cardiovasc Surg 153(5):1082\u20131083. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.09.017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10372_CR19","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/s0002-9149(98)00140-4","volume":"81","author":"TC Yeo","year":"1998","unstructured":"Yeo TC, Dujardin KS, Tei C, Mahoney DW, McGoon MD, Seward JB (1998) Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. Am J Cardiol 81(9):1157\u20131161. https:\/\/doi.org\/10.1016\/s0002-9149(98)00140-4","journal-title":"Am J Cardiol"},{"issue":"4","key":"10372_CR20","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/0002-8703(93)90121-o","volume":"125","author":"PA Ribeiro","year":"1993","unstructured":"Ribeiro PA, al Zaibag M, Abdullah M (1993) Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis. Am Heart J 125(4):1110\u20131114. https:\/\/doi.org\/10.1016\/0002-8703(93)90121-o","journal-title":"Am Heart J"},{"issue":"6","key":"10372_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejim.2005.02.012","volume":"16","author":"S Maoqin","year":"2005","unstructured":"Maoqin S, Guoxiang H, Zhiyuan S et al (2005) The clinical and hemodynamic results of mitral balloon valvuloplasty for patients with mitral stenosis complicated by severe pulmonary hypertension. Eur J Intern Med 16(6):413\u2013418. https:\/\/doi.org\/10.1016\/j.ejim.2005.02.012","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10372_CR22","first-page":"942","volume":"13","author":"ME Fawzy","year":"2004","unstructured":"Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA (2004) Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 13(6):942\u2013947; discussion 947\u2013948","journal-title":"J Heart Valve Dis"},{"issue":"5","key":"10372_CR23","first-page":"485","volume":"17","author":"ME Fawzy","year":"2008","unstructured":"Fawzy ME, Osman A, Nambiar V et al (2008) Immediate and long-term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension. J Heart Valve Dis 17(5):485\u2013491","journal-title":"J Heart Valve Dis"},{"issue":"12","key":"10372_CR24","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.hlc.2012.07.008","volume":"21","author":"T Yan","year":"2012","unstructured":"Yan T, Zhang GX, Li BL, Zhong K, Xu ZY, Han L (2012) Pulmonary artery haemodynamic properties in patients with pulmonary hypertension secondary to rheumatic mitral stenosis. Heart Lung Circ 21(12):782\u2013786. https:\/\/doi.org\/10.1016\/j.hlc.2012.07.008","journal-title":"Heart Lung Circ"},{"issue":"8","key":"10372_CR25","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00059-016-4509-2","volume":"42","author":"L Pourafkari","year":"2017","unstructured":"Pourafkari L, Ghaffari S, Ahmadi M, Tajlil A, Aslanabadi N, Nader ND (2017) Pulmonary hypertension in rheumatic mitral stenosis revisited. Herz 42(8):746\u2013751. https:\/\/doi.org\/10.1007\/s00059-016-4509-2","journal-title":"Herz"},{"issue":"2","key":"10372_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jtcvs.2016.02.038","volume":"152","author":"B Yang","year":"2016","unstructured":"Yang B, DeBenedictus C, Watt T et al (2016) The impact of concomitant pulmonary hypertension on early and late outcomes following surgery for mitral stenosis. J Thorac Cardiovasc Surg 152(2):394-400.e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2016.02.038","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10372_CR27","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1161\/CIR.0000000000000932","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e35\u2013e71. https:\/\/doi.org\/10.1161\/CIR.0000000000000932","journal-title":"Circulation"},{"issue":"4","key":"10372_CR28","doi-asserted-by":"publisher","first-page":"e000748","DOI":"10.1161\/JAHA.113.000748","volume":"3","author":"H Patel","year":"2014","unstructured":"Patel H, Desai M, Tuzcu EM, Griffin B, Kapadia S (2014) Pulmonary hypertension in mitral regurgitation. J Am Heart Assoc 3(4):e000748. https:\/\/doi.org\/10.1161\/JAHA.113.000748","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10372_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jtcvs.2010.11.031","volume":"142","author":"S Kainuma","year":"2011","unstructured":"Kainuma S, Taniguchi K, Toda K et al (2011) Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 142(4):783\u2013792. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.11.031","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10372_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCIMAGING.113.001184","volume":"7","author":"WL Miller","year":"2014","unstructured":"Miller WL, Mahoney DW, Enriquez-Sarano M (2014) Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: independent effect of pulmonary hypertension. Circ Cardiovasc Imaging 7(2):330\u2013336. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.001184","journal-title":"Circ Cardiovasc Imaging"},{"issue":"16","key":"10372_CR31","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1136\/hrt.2009.186486","volume":"96","author":"T Le Tourneau","year":"2010","unstructured":"Le Tourneau T, Richardson M, Juthier F et al (2010) Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart Br Card Soc 96(16):1311\u20131317. https:\/\/doi.org\/10.1136\/hrt.2009.186486","journal-title":"Heart Br Card Soc"},{"issue":"6","key":"10372_CR32","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jtcvs.2011.08.030","volume":"142","author":"M Ghoreishi","year":"2011","unstructured":"Ghoreishi M, Evans CF, DeFilippi CR et al (2011) Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142(6):1439\u20131452. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.08.030","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"25","key":"10372_CR33","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2016.03.589","volume":"67","author":"A Mentias","year":"2016","unstructured":"Mentias A, Patel K, Patel H et al (2016) Effect of pulmonary vascular pressures on long-term outcome in patients with primary mitral regurgitation. J Am Coll Cardiol 67(25):2952\u20132961. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.589","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10372_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/eurheartj\/ehq294","volume":"32","author":"A Barbieri","year":"2011","unstructured":"Barbieri A, Bursi F, Grigioni F et al (2011) Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32(6):751\u2013759. https:\/\/doi.org\/10.1093\/eurheartj\/ehq294","journal-title":"Eur Heart J"},{"issue":"22","key":"10372_CR35","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/j.jacc.2020.09.609","volume":"76","author":"O Ben-Yehuda","year":"2020","unstructured":"Ben-Yehuda O, Shahim B, Chen S et al (2020) Pulmonary hypertension in transcatheter mitral valve repair for secondary mitral regurgitation: the COAPT trial. J Am Coll Cardiol 76(22):2595\u20132606. https:\/\/doi.org\/10.1016\/j.jacc.2020.09.609","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10372_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jamacardio.2019.4428","volume":"5","author":"R Al-Bawardy","year":"2020","unstructured":"Al-Bawardy R, Vemulapalli S, Thourani VH et al (2020) Association of pulmonary hypertension with clinical outcomes of transcatheter mitral valve repair. JAMA Cardiol 5(1):47\u201356. https:\/\/doi.org\/10.1001\/jamacardio.2019.4428","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10372_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ejcts\/ezab389","volume":"60","author":"A Vahanian","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F et al (2021) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 60(4):727\u2013800. https:\/\/doi.org\/10.1093\/ejcts\/ezab389","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"issue":"2","key":"10372_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.tcm.2020.12.005","volume":"32","author":"MT Maeder","year":"2022","unstructured":"Maeder MT, Weber L, Rickli H (2022) Pulmonary hypertension in aortic valve stenosis. Trends Cardiovasc Med 32(2):73\u201381. https:\/\/doi.org\/10.1016\/j.tcm.2020.12.005","journal-title":"Trends Cardiovasc Med"},{"key":"10372_CR39","doi-asserted-by":"publisher","first-page":"381787","DOI":"10.1155\/2011\/381787","volume":"2011","author":"TL Kiefer","year":"2011","unstructured":"Kiefer TL, Bashore TM (2011) Pulmonary hypertension related to left-sided cardiac pathology. Pulm Med 2011:381787. https:\/\/doi.org\/10.1155\/2011\/381787","journal-title":"Pulm Med"},{"issue":"1","key":"10372_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0002-8703(93)90067-j","volume":"125","author":"K Silver","year":"1993","unstructured":"Silver K, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J (1993) Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J 125(1):146\u2013150. https:\/\/doi.org\/10.1016\/0002-8703(93)90067-j","journal-title":"Am Heart J"},{"issue":"2","key":"10372_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/2045893217697709","volume":"7","author":"R Parikh","year":"2017","unstructured":"Parikh R, Varghese B, Khatoon HN, Kovach JA, Kavinsky CJ, Tandon R (2017) Increased mortality from complications of pulmonary hypertension in patients undergoing transcatheter aortic valve replacement. Pulm Circ 7(2):391\u2013398. https:\/\/doi.org\/10.1177\/2045893217697709","journal-title":"Pulm Circ"},{"issue":"4","key":"10372_CR42","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/s0735-1097(02)02002-8","volume":"40","author":"JF Malouf","year":"2002","unstructured":"Malouf JF, Enriquez-Sarano M, Pellikka PA et al (2002) Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 40(4):789\u2013795. https:\/\/doi.org\/10.1016\/s0735-1097(02)02002-8","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10372_CR43","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/jocs.14309","volume":"34","author":"RV Rocha","year":"2019","unstructured":"Rocha RV, Friedrich JO, Hong K et al (2019) Aortic valve replacement with pulmonary hypertension: meta-analysis of 70 676 patients. J Card Surg 34(12):1617\u20131625. https:\/\/doi.org\/10.1111\/jocs.14309","journal-title":"J Card Surg"},{"issue":"1","key":"10372_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.athoracsur.2007.02.094","volume":"84","author":"RG Pai","year":"2007","unstructured":"Pai RG, Varadarajan P, Kapoor N, Bansal RC (2007) Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 84(1):80\u201385. https:\/\/doi.org\/10.1016\/j.athoracsur.2007.02.094","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10372_CR45","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.jtcvs.2011.02.028","volume":"141","author":"SJ Melby","year":"2011","unstructured":"Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ (2011) Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 141(6):1424\u20131430. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.02.028","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10372_CR46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.amjcard.2010.11.031","volume":"107","author":"I Ben-Dor","year":"2011","unstructured":"Ben-Dor I, Goldstein SA, Pichard AD et al (2011) Clinical profile, prognostic implication, and response to treatment of pulmonary hypertension in patients with severe aortic stenosis. Am J Cardiol 107(7):1046\u20131051. https:\/\/doi.org\/10.1016\/j.amjcard.2010.11.031","journal-title":"Am J Cardiol"},{"issue":"291","key":"10372_CR47","first-page":"589","volume":"80","author":"DP Naidoo","year":"1991","unstructured":"Naidoo DP, Mitha AS, Vythilingum S, Chetty S (1991) Pulmonary hypertension in aortic regurgitation: early surgical outcome. Q J Med 80(291):589\u2013595","journal-title":"Q J Med"},{"issue":"3","key":"10372_CR48","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.athoracsur.2009.05.025","volume":"88","author":"S Khandhar","year":"2009","unstructured":"Khandhar S, Varadarajan P, Turk R et al (2009) Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg 88(3):752\u2013756. https:\/\/doi.org\/10.1016\/j.athoracsur.2009.05.025","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"10372_CR49","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0735-1097(96)00399-3","volume":"28","author":"MM Givertz","year":"1996","unstructured":"Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS (1996) Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol 28(7):1775\u20131780. https:\/\/doi.org\/10.1016\/S0735-1097(96)00399-3","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10372_CR50","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.healun.2014.11.003","volume":"34","author":"M Guazzi","year":"2015","unstructured":"Guazzi M, Gomberg-Maitland M, Arena R (2015) Pulmonary hypertension in heart failure with preserved ejection fraction. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 34(3):273\u2013281. https:\/\/doi.org\/10.1016\/j.healun.2014.11.003","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"issue":"9","key":"10372_CR51","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.healun.2012.06.002","volume":"31","author":"JC Fang","year":"2012","unstructured":"Fang JC, DeMarco T, Givertz MM et al (2012) World Health Organization pulmonary hypertension group 2: pulmonary hypertension due to left heart disease in the adult\u2013a summary statement from the pulmonary hypertension council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 31(9):913\u2013933. https:\/\/doi.org\/10.1016\/j.healun.2012.06.002","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"issue":"6","key":"10372_CR52","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.chest.2019.06.010","volume":"156","author":"RL Benza","year":"2019","unstructured":"Benza RL, Doyle M, Lasorda D et al (2019) Monitoring pulmonary arterial hypertension using an implantable hemodynamic sensor. Chest 156(6):1176\u20131186. https:\/\/doi.org\/10.1016\/j.chest.2019.06.010","journal-title":"Chest"},{"issue":"3","key":"10372_CR53","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5500\/wjt.v6.i3.542","volume":"6","author":"R Davey","year":"2016","unstructured":"Davey R, Raina A (2016) Hemodynamic monitoring in heart failure and pulmonary hypertension: from analog tracings to the digital age. World J Transplant 6(3):542\u2013547. https:\/\/doi.org\/10.5500\/wjt.v6.i3.542","journal-title":"World J Transplant"},{"issue":"2","key":"10372_CR54","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1086\/681264","volume":"5","author":"AW Trammell","year":"2015","unstructured":"Trammell AW, Pugh ME, Newman JH, Hemnes AR, Robbins IM (2015) Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ 5(2):356\u2013363. https:\/\/doi.org\/10.1086\/681264","journal-title":"Pulm Circ"},{"issue":"1","key":"10372_CR55","first-page":"36","volume":"56","author":"GS Vlachogeorgos","year":"2015","unstructured":"Vlachogeorgos GS, Daskalopoulos N, Blatsiotis P, Kourbeti IS, Mantas I, Stathopoulos GT (2015) Bosentan for patients with echocardiographic evidence of pulmonary hypertension due to long-standing rheumatic mitral stenosis. Hell J Cardiol HJC Hell Kardiologike Epitheorese 56(1):36\u201343","journal-title":"Hell J Cardiol HJC Hell Kardiologike Epitheorese"},{"issue":"7","key":"10372_CR56","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.hlc.2013.12.014","volume":"23","author":"G Jiang","year":"2014","unstructured":"Jiang G, Li B, Zhang G, Xu E, Liu Y, Xu Z (2014) Effects of sildenafil on prognosis in patients with pulmonary hypertension after left-sided valvular surgery. Heart Lung Circ 23(7):680\u2013685. https:\/\/doi.org\/10.1016\/j.hlc.2013.12.014","journal-title":"Heart Lung Circ"},{"issue":"1","key":"10372_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/CIRCHEARTFAILURE.110.944694","volume":"4","author":"M Guazzi","year":"2011","unstructured":"Guazzi M, Vicenzi M, Arena R, Guazzi MD (2011) PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail 4(1):8\u201317. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.944694","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10372_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","volume":"115","author":"GD Lewis","year":"2007","unstructured":"Lewis GD, Lachmann J, Camuso J et al (2007) Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115(1):59\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.626226","journal-title":"Circulation"},{"issue":"19","key":"10372_CR59","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.111.081125","volume":"125","author":"BR Lindman","year":"2012","unstructured":"Lindman BR, Zajarias A, Madrazo JA et al (2012) Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. Circulation 125(19):2353\u20132362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.081125","journal-title":"Circulation"},{"issue":"6","key":"10372_CR60","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jtcvs.2006.08.035","volume":"132","author":"JK Shim","year":"2006","unstructured":"Shim JK, Choi YS, Oh YJ, Kim DH, Hong YW, Kwak YL (2006) Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery. J Thorac Cardiovasc Surg 132(6):1420\u20131425. https:\/\/doi.org\/10.1016\/j.jtcvs.2006.08.035","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10372_CR61","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1053\/j.jvca.2018.12.023","volume":"33","author":"E Ram","year":"2019","unstructured":"Ram E, Sternik L, Klempfner R et al (2019) Sildenafil for pulmonary hypertension in the early postoperative period after mitral valve surgery. J Cardiothorac Vasc Anesth 33(6):1648\u20131656. https:\/\/doi.org\/10.1053\/j.jvca.2018.12.023","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"4","key":"10372_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.fjc.0000155386.49103.ce","volume":"45","author":"D Ikeda","year":"2005","unstructured":"Ikeda D, Tsujino I, Ohira H et al (2005) Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension. J Cardiovasc Pharmacol 45(4):286\u2013289. https:\/\/doi.org\/10.1097\/01.fjc.0000155386.49103.ce","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10372_CR63","first-page":"333","volume":"19","author":"SY Kim","year":"2010","unstructured":"Kim SY, Shim JK, Shim YH, Hong SW, Choi KH, Kwak YL (2010) Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery. J Heart Valve Dis 19(3):333\u2013340","journal-title":"J Heart Valve Dis"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-023-10372-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-023-10372-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T09:29:15Z","timestamp":1709198955000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-023-10372-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["10372"],"URL":"https:\/\/doi.org\/10.1007\/s10741-023-10372-9","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"15 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Relationships with industry (all unrelated to this work). Dr. Amin Yehya serves on the advisory board and on the speaker\u2019s bureau for Merck. Drs. Patel, D\u2019Souza, and Sahni have no financial disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}